212 related articles for article (PubMed ID: 15070680)
1. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.
Hjortoe GM; Petersen LC; Albrektsen T; Sorensen BB; Norby PL; Mandal SK; Pendurthi UR; Rao LV
Blood; 2004 Apr; 103(8):3029-37. PubMed ID: 15070680
[TBL] [Abstract][Full Text] [Related]
2. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
3. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
[TBL] [Abstract][Full Text] [Related]
4. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion.
Paul S; Das K; Ghosh A; Chatterjee A; Bhoumick A; Basu A; Sen P
J Thromb Haemost; 2023 Dec; 21(12):3522-3538. PubMed ID: 37579880
[TBL] [Abstract][Full Text] [Related]
5. Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling.
Zelaya H; Grunz K; Nguyen TS; Habibi A; Witzler C; Reyda S; Gonzalez-Menendez I; Quintanilla-Martinez L; Bosmann M; Weiler H; Ruf W
Blood; 2024 Mar; 143(10):845-857. PubMed ID: 38096370
[TBL] [Abstract][Full Text] [Related]
6. Tissue Factor promotes breast cancer stem cell activity in vitro.
Shaker H; Harrison H; Clarke R; Landberg G; Bundred NJ; Versteeg HH; Kirwan CC
Oncotarget; 2017 Apr; 8(16):25915-25927. PubMed ID: 28033108
[TBL] [Abstract][Full Text] [Related]
7. TF-FVIIa PAR2-β-Arrestin Signaling Sustains Organ Dysfunction in Coxsackievirus B3 Infection of Mice.
Kespohl M; Goetzke CC; Althof N; Bredow C; Kelm N; Pinkert S; Bukur T; Bukur V; Grunz K; Kaur D; Heuser A; Mülleder M; Sauter M; Klingel K; Weiler H; Berndt N; Gaida MM; Ruf W; Beling A
Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):843-865. PubMed ID: 38385286
[TBL] [Abstract][Full Text] [Related]
8. Factor VII deficiency impairs cutaneous wound healing in mice.
Xu Z; Xu H; Ploplis VA; Castellino FJ
Mol Med; 2010; 16(5-6):167-76. PubMed ID: 20454518
[TBL] [Abstract][Full Text] [Related]
9. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
10. TF/PAR2 Signaling Axis Supports the Protumor Effect of Neutrophil Extracellular Traps (NETs) on Human Breast Cancer Cells.
Martins-Cardoso K; Maçao A; Souza JL; Silva AG; König S; Martins-Gonçalves R; Hottz ED; Rondon AMR; Versteeg HH; Bozza PT; Almeida VH; Monteiro RQ
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201433
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy.
Huo H; Feng Y; Tang Q
Cancer Chemother Pharmacol; 2024 May; 93(5):397-410. PubMed ID: 38172304
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between Circulating Tumor Cells and Plasma Proteins-Impact on Coagulation and Anticoagulation.
Wang Y; Schneider SW; Gorzelanny C
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37296987
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer.
Ahmadi SE; Shabannezhad A; Kahrizi A; Akbar A; Safdari SM; Hoseinnezhad T; Zahedi M; Sadeghi S; Mojarrad MG; Safa M
Biomark Res; 2023 Jun; 11(1):60. PubMed ID: 37280670
[TBL] [Abstract][Full Text] [Related]
14. The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans.
Hassan N; Efing J; Kiesel L; Bendas G; Götte M
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900315
[TBL] [Abstract][Full Text] [Related]
15. CD142 promotes trophoblast cell migration by inhibiting BCL2-related autophagic degradation of IL-8.
Zheng L; Tang R; Shi L; Zhou Z; Song J; Lu Z
In Vitro Cell Dev Biol Anim; 2023 Feb; 59(2):131-141. PubMed ID: 36847889
[TBL] [Abstract][Full Text] [Related]
16. Trypsin may be associated with duodenal eosinophils through the expression of PAR2 in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities.
Agawa S; Futagami S; Yamawaki H; Tsushima R; Higuchi K; Habiro M; Kawawa R; Kodaka Y; Ueki N; Watanabe Y; Gudis K; Ohashi R; Iwakiri K
PLoS One; 2022; 17(10):e0275341. PubMed ID: 36264979
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor: a neglected role in cancer biology.
Li H; Yu Y; Gao L; Zheng P; Liu X; Chen H
J Thromb Thrombolysis; 2022 Jul; 54(1):97-108. PubMed ID: 35763169
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration.
Dhami SPS; Patmore S; Comerford C; Byrne CM; Cavanagh B; Castle J; Kirwan CC; Kenny M; Schoen I; O'Donnell JS; O'Sullivan JM
J Thromb Haemost; 2022 Oct; 20(10):2350-2365. PubMed ID: 35722954
[TBL] [Abstract][Full Text] [Related]
19. CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer.
Sang X; Belmessabih N; Wang R; Stephen P; Lin SX
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205737
[TBL] [Abstract][Full Text] [Related]
20. Changes of fibrinolytic system in thrombolytic resuscitation of pulmonary thromboembolism-induced cardiac arrest model.
Tong N; Li C
Int Wound J; 2021 Dec; 18(6):874-880. PubMed ID: 33942504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
